Optimization of AAV9-SMN gene therapy for Spinal Muscular Atrophy

被引：0
|
作者：
Besse, Aurore [1 ]
Marais, Thibaut [1 ]
Astord, Stephanie [1 ]
Roda, Marianne [1 ]
Tanguy, Yannick [1 ]
Clement, Yan [1 ]
Barkats, Martine [1 ]
机构：
[1] UPMC, UM76, CNRS, INSERM,FRE3617,U974,Inst Myol, Paris, France
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P146
引用
收藏
页码：A102 / A103
页数：2
相关论文
共 50 条
  • [1] Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy
    Reilly, Aoife
    Yaworski, Rebecca
    Beauvais, Ariane
    Schneider, Bernard L.
    Kothary, Rashmi
    HUMAN MOLECULAR GENETICS, 2024, 33 (06) : 510 - 519
  • [2] Systemic AAV9-SMN delivery is crucial for Spinal Muscular Atrophy (SMA) in mice
    Besse, A.
    Roda, M.
    Astord, S.
    Marais, T.
    Barkats, M.
    HUMAN GENE THERAPY, 2014, 25 (11) : A103 - A103
  • [3] Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy
    Aoife Reilly
    Marc-Olivier Deguise
    Ariane Beauvais
    Rebecca Yaworski
    Simon Thebault
    Daniel R. Tessier
    Vincent Tabard-Cossa
    Niko Hensel
    Bernard L. Schneider
    Rashmi Kothary
    Gene Therapy, 2022, 29 : 544 - 554
  • [4] Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy
    Reilly, Aoife
    Deguise, Marc-Olivier
    Beauvais, Ariane
    Yaworski, Rebecca
    Thebault, Simon
    Tessier, Daniel R.
    Tabard-Cossa, Vincent
    Hensel, Niko
    Schneider, Bernard L.
    Kothary, Rashmi
    GENE THERAPY, 2022, 29 (09) : 544 - 554
  • [5] Systemic AAV9 Gene Therapy of Spinal Muscular Atrophy
    Barkats, M.
    Benkhelifa-Ziyyat, S.
    Marais, T.
    Dominguez, E.
    Duque, S.
    Roda, M.
    Astord, S.
    Carcenac, R.
    Voit, T.
    HUMAN GENE THERAPY, 2011, 22 (10) : A16 - A17
  • [6] AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
    Rithu Pattali
    Yongchao Mou
    Xue-Jun Li
    Gene Therapy, 2019, 26 : 287 - 295
  • [7] AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
    Pattali, Rithu
    Mou, Yongchao
    Li, Xue-Jun
    GENE THERAPY, 2019, 26 (7-8) : 287 - 295
  • [8] SMN replacement gene therapy for spinal muscular atrophy: clinical development
    Azzouz, Mimoun
    HUMAN GENE THERAPY, 2013, 24 (05) : A10 - A10
  • [9] AAV-mediated augmentation of SMN levels for spinal muscular atrophy
    Cheng, S. H.
    Passini, M. A.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 650 - 650
  • [10] AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/- spinal muscular atrophy mice
    Brown, Sharon J.
    Soltic, Darija
    Synowsky, Silvia A.
    Shirran, Sally L.
    Chilcott, Ellie
    Shorrock, Hannah K.
    Gillingwater, Thomas H.
    Yanez-Munoz, Rafael J.
    Schneider, Bernard
    Bowerman, Melissa
    Fuller, Heidi R.
    HUMAN MOLECULAR GENETICS, 2023, 32 (20) : 2950 - 2965
12345